Le Lézard
Classified in: Science and technology
Subject: Personnel

Drawbridge Names Thomas Fallucco Chief Revenue Officer


Drawbridge, a premier provider of cybersecurity software and solutions to the alternative investment industry, today announced the appointment of Thomas Fallucco as Chief Revenue Officer (CRO). Fallucco will be responsible for driving continued growth while expanding a global footprint through international business and enhancing client relationships and service.

Fallucco brings over 20 years of leadership experience across sales, partnerships and marketing to his role at Drawbridge, with extensive experience serving financial services and funds within the alternative investment space. Prior to Drawbridge, Fallucco served as CRO at Kobiton where he assisted in the acquisition of competitor Mobile Labs, designed the organization for scale, aligned client-centric resources and rebuilt the new logo sales team. Earlier in his career, Fallucco held leadership roles at Secureworks, where he led the global channel team, and subsequently oversaw U.S. and Canadian sales teams.

"As the cybersecurity landscape continues to evolve, Drawbridge is committed to providing our clients best-in-breed software coupled with deep industry and technical expertise to safeguard them against internal and external threats," said Jason Elmer, Founder and CEO, Drawbridge. "Thomas' proven track record scaling many high-growth technology companies by delivering innovative strategies and exceptional client service will be invaluable to us as we continue our period of hyper-growth."

"The remarkable success and expansion Drawbridge has recorded to date is a testament to the extraordinary team, industry-leading platform and services the company provides to the alternative investment community," said Thomas Fallucco, CRO, Drawbridge. "Drawbridge is ideally positioned to help firms manage today's dynamic emerging threats and regulatory requirements, and I am thrilled to join Jason and the team to help accelerate growth at such an exciting time in the company's history."

About Drawbridge:

Drawbridge is a premier provider of cybersecurity software and solutions to the alternative investment industry. Its proprietary platform helps firms manage their governance, risk and compliance (GRC) requirements while combatting sophisticated cyber threats and third-party risks. Drawbridge's platform connects business, compliance and IT to empower firms to centralize and manage their most robust security programs, improve their risk profile and raise institutional capital. With a tested team focused on value delivery and a 600+ strong customer base, Drawbridge offers unmatched customer service and flexibility to help businesses proactively manage vulnerabilities, plan for growth, and reduce complexity.


These press releases may also interest you

at 23:14
As the graduation season approaches, COOFANDY, the modern men's essentials designer, is rolling out the red carpet for graduates with its "Style for Celebrations" theme. The brand encourages participants to share their graduation highlights using...

at 23:05
AI is the CIO's top priority, according to findings of Lenovo's third annual global CIO report. Inside the Tornado: How AI is Reshaping Corporate IT Today, reveals that while CIOs need to adopt and scale AI urgently, their ambitions are threatened by...

at 23:00
OPUS, the opportunity community for business builders, today announces a partnership with leading Dubai-based think-tank, Fiker Institute, as it launches in the...

at 23:00
Amkan Ventures, officially launched today and is announcing a $10M Fund of Funds (FoF) dedicated to backing emerging venture managers in the US. The new FoF is building a portfolio of a dozen funds across tech-enabled industries. Amkan Ventures...

at 22:33
The report titled "Building Energy Management Systems Market by Component (Hardware, Services, Software), Type (Integrated Building Energy Management Systems, Standalone Building Energy Management Systems), Application, Deployment Mode, End-Use -...

at 22:15
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...



News published on and distributed by: